Arbutus Biopharma Corp (ABUS) stock news · rev $14.1M
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
This ABUS news page leads with what Arbutus Biopharma Corp filed — not a scraped headline mill.
No cached 8-K sentence for ABUS yet. We will not pad this page with generic market recap.
Latest reported ABUS revenue for 2025-12-31 was $14.1M. Net income was -$33.5M. Revenue was up 128.2% from 2024-12-31 to 2025-12-31. ABUS currently screens at market cap $883.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ABUS stock page; for the tape open the quote page.
ABUS stock news FAQ
What are ABUS's latest revenue and net income?
Latest cached Arbutus Biopharma Corp (ABUS) revenue for Dec 31, 2025 was $14.1M. Net income was -$33.5M. Statements: https://lician.com/financials/abus
How did ABUS revenue change from the prior cached period?
Cached Arbutus Biopharma Corp (ABUS) revenue was up 128.2% from $6.2M (Dec 31, 2024) to $14.1M (Dec 31, 2025). Statements: https://lician.com/financials/abus
What is ABUS's market cap?
Arbutus Biopharma Corp (ABUS) market cap is $883.0M on the latest cached fundamentals snapshot.
What kind of company is ABUS?
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Where is ABUS stock news listed?
Cached stock news for Arbutus Biopharma Corp (ABUS) is listed at https://lician.com/news/abus. Filings: https://lician.com/sec/abus
Not investment advice.